Let’s Get Started

BREAKTHROUGH CONSORTIUM FOR OLFACTORY HEALTH

The Breakthrough Consortium for Olfactory Health (BeCOH) brings together patient-facing organizations, researchers, clinicians, government agencies, diagnostic and pharmaceutical companies to drive forward developments in the testing and treatment of olfactory dysfunction, a significant yet under-recognized public health issue.

VISION

Making universal prevention, detection and effective treatment of olfactory dysfunction a reality

MISSION

To establish evidence-based clinical, regulatory and access pathways to improve patient diagnosis and treatment for olfactory dysfunction.

STEERING COMMITTEE

CO-CHAIR

Duncan Boak
CEO, Fifth Sense

CO-CHAIR

Valentina Parma
Assistant Director and Assistant Member, Monel

MEMBER

Lisa Huang
Partner, Curie.bio

MEMBER

Joshua Levy
NIDCD Clinical Director, Co-Director of NIH National Smell and Taste Cente

MEMBER

Patricia Lucas-Schnarre
CEO, Ahersla Health; Founder of the Olfaction and Gustation Industry Group

MEMBER

Andy Mulvaney
CEO, RhinoTherapeutics

MEMBER

Zara Patel
Professor in Rhinology, Stanford University

ADVISOR

Nancy Rawson
Executive Vice-President, Monell

CONTACT

    The Breakthrough Consortium for Olfactory Health (BeCOH)
    Linkedin